Free Trial
NASDAQ:TLRY

Tilray Brands (TLRY) Stock Price, News & Analysis

Tilray Brands logo
$0.58 -0.06 (-8.88%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.59 +0.01 (+0.95%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tilray Brands Stock (NASDAQ:TLRY)

Key Stats

Today's Range
$0.58
$0.63
50-Day Range
$0.36
$0.68
52-Week Range
$0.35
$2.15
Volume
35.23 million shs
Average Volume
31.13 million shs
Market Capitalization
$584.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.92
Consensus Rating
Hold

Company Overview

Tilray Brands Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

TLRY MarketRank™: 

Tilray Brands scored higher than 38% of companies evaluated by MarketBeat, and ranked 655th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tilray Brands has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tilray Brands' stock forecast and price target.
  • Earnings Growth

    Earnings for Tilray Brands are expected to grow in the coming year, from ($0.20) to ($0.10) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tilray Brands is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tilray Brands is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tilray Brands has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Tilray Brands' valuation and earnings.
  • Percentage of Shares Shorted

    20.64% of the float of Tilray Brands has been sold short.
  • Short Interest Ratio / Days to Cover

    Tilray Brands has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Tilray Brands has recently increased by 3.18%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Tilray Brands does not currently pay a dividend.

  • Dividend Growth

    Tilray Brands does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.64% of the float of Tilray Brands has been sold short.
  • Short Interest Ratio / Days to Cover

    Tilray Brands has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Tilray Brands has recently increased by 3.18%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Tilray Brands has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Tilray Brands this week, compared to 12 articles on an average week.
  • Search Interest

    33 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 43% compared to the previous 30 days.
  • MarketBeat Follows

    60 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 94% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tilray Brands insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.60% of the stock of Tilray Brands is held by insiders.

  • Percentage Held by Institutions

    Only 9.35% of the stock of Tilray Brands is held by institutions.

  • Read more about Tilray Brands' insider trading history.
Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray Brands and its competitors with MarketBeat's FREE daily newsletter.

TLRY Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Tilray Brands Sees Unusually Large Options Volume (NASDAQ:TLRY)
See More Headlines

TLRY Stock Analysis - Frequently Asked Questions

Tilray Brands' stock was trading at $1.33 at the beginning of 2025. Since then, TLRY stock has decreased by 56.4% and is now trading at $0.5805.

Tilray Brands, Inc. (NASDAQ:TLRY) released its earnings results on Tuesday, April, 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The company earned $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray Brands had a negative trailing twelve-month return on equity of 7.40% and a negative net margin of 113.85%.
Read the conference call transcript
.

Tilray Brands (TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Top institutional investors of Tilray Brands include Baader Bank Aktiengesellschaft (0.03%). Insiders that own company stock include Brendan Kennedy, Irwin D Simon, Denise M Faltischek, Mitchell Gendel and Carl A Merton.
View institutional ownership trends
.

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), Humana (HUM), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
4/08/2025
Today
7/12/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLRY
Previous Symbol
NASDAQ:TLRY
CIK
1731348
Fax
N/A
Employees
2,650
Year Founded
N/A

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+230.2%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$244.98 million
Net Margins
-113.85%
Pretax Margin
-115.20%
Return on Equity
-7.40%
Return on Assets
-6.02%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
2.62
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$788.94 million
Price / Sales
0.74
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.14 per share
Price / Book
0.14

Miscellaneous

Outstanding Shares
1,006,500,000
Free Float
1,000,457,000
Market Cap
$584.27 million
Optionable
Optionable
Beta
1.82
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:TLRY) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners